Big Pharma creates experimental cholesterol vaccine

Friday, November 13, 2015 by

If you think vaccines were just made for diseases, then think again. A cholesterol-lowering vaccine will soon be at a doctor’s office near you – brought to you by the University of New Mexico and the National Institute of Health. That’s right folks — a cholesterol-lowering vaccine.

Dr. Bryce Chakerian says, “One of the most exciting things about this new vaccine is it seems to be much more effective than statins alone.” Oh good, because we already know how effective statins are.

The vaccine targets and reduces a protein, PSK9, which bonds to LDL cholesterol receptors and prevents LDL cholesterol from being removed from the blood.

Oddly enough, the first prescription drug to target PSK9 was only just approved by the FDA in July 2015. It was approved only for use to treat a specific genetic condition known as heterozygous familial hypercholesterolemia. Isn’t it strange how there seems to be quite the rush to push this new “vaccine” on the masses? After all, there is no better guinea pig than the public.

Supposedly, the vaccine will not pose the same side effects as statins. Sure, the vaccine will probably contain toxic adjuvants to make it more effective, but the neurotoxins will probably make you stupid enough not to realize that you’re experiencing side effects. So, I guess that’s that.

Why diet and exercise when you can get a shot to make it all better, anyway?


Signup for our newsletter, we will respect your inbox and privacy


comments powered by Disqus

Please like our Facebook Page
Show us your support by liking our page!
Close This Box